Healey & AMG Center announces top line results in ALS platform trial with CMN-Au8
Healey & AMG Center announces top line results in ALS platform trial with CMN-Au8
Healey Center News & Events
Narrow your search for a specific article by using the search box and/or filters.
77 results
Healey Center announces results from the HEALEY ALS Platform Trial with verdiperstat
Results from the regimen evaluating verdiperstat, an oral myeloperoxidase inhibitor that is thought to reduce neuro-inflammation in adults with amyotrophic lateral sclerosis (ALS).
Investigational drug ABBV-CLS-7262 initiates design phase for entry into the HEALEY ALS Platform Trial
The Healey & AMG Center for ALS at Mass General and Calico Life Sciences LLC recently signed an agreement to work together to test ABBV-CLS-7262 in the HEALEY ALS Platform Trial.
2022 Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing
The Sean. M. Healey & AMG Center for ALS at Massachusetts General Hospital is accepting nominations for the 2022 Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing in acknowledgement of the important scientific work being done in ALS.
Baseline Speech Assessment and Vital Capacity Measured Remotely and in Clinic in the HEALEY ALS Platform Trial
A team of researchers from the Healey ALS Platform Trial Biomarkers and Outcomes Measures taskforce have released a poster at the European Network to Cure ALS 2022 International Meeting that includes data around remote measurement of baseline speech assessment and vital capacity (VC), a measure of respiratory function.
Director of Sean M. Healey & AMG Center for ALS Named Co-chair of NINDS ALS Optimizing Clinical Research Strategic Planning Effort
Merit Cudkowicz, MD, MSc, director of the Sean M. Healey Center for ALS, has been named co-chair of the Optimizing Clinical Research Working Group for the 2022 National Institute of Neurological Disorders and Stroke (NINDS) ALS Strategic Planning Effort.
Call for Nominations: 2022 Healey Center International Prize for Innovation in ALS
The Sean M. Healey International Prize for Innovation in ALS Research recognizes an individual or a team of investigators who catalyze exceptional discoveries leading to a transformative advance in therapy development in ALS.
Request for Nominations: Gupta Family Endowed Prize for Innovation in ALS Care
The Gupta Family Endowed Prize for Innovation in ALS Care is an annual global prize to honor ground-breaking new approaches that lead to exceptional care for individuals living with amyotrophic lateral sclerosis (ALS).
healey-platform-trial-hopes-to-bring-new-treatments-faster
healey-platform-trial-hopes-to-bring-new-treatments-faster. healey-platform-trial-hopes-to-bring-new-treatments-faster. This study is really the first comprehensive platform for ALS drug development, where a central infrastructure is shared between a
The HEALEY ALS Platform Trial announces first participants enrolled for investigational product SLS-005 (Trehalose)
The HEALEY ALS Platform Trial announces first participants enrolled for investigational product SLS-005 (Trehalose). The HEALEY ALS Platform Trial announces first participants enrolled for investigational product SLS-005 (Trehalose). BOSTON – The
Showing 1 - 10 of 77 results
Transforming Medicine Through Innovation
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.